Munafa Stock Market Course + Intraday & FNO calls 
Myriad Genetics (MYGN) Technical (Analysis) Reports Myriad Genetics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Myriad Genetics (MYGN)
Technical Analysis Report for NASDAQ stock MYGN Myriad Genetics. Dated: 29 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock MYGN Myriad Genetics then click here. or read Experts views on Myriad Genetics or Forecast & share price targets of Myriad Genetics
Myriad Genetics Opened at 6.57 and Closed at: 6.31, which is -2.69% of previous session's close. It moved within a range of 6.29 and 6.57
The session was a Bearish session with an average volume of 663300, which is -41.17% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Dead cross was found 9 days back on short term averages
Support for tomorrow is 6.16 and resistance for tomorrow is 6.44
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 6.21, 6.11 resistance for tomorrow's hourly charts is 6.49, 6.67
10 Day SMA for Myriad Genetics (MYGN) is 6.67 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Myriad Genetics (MYGN) is 6.94 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Myriad Genetics (MYGN) is 7.16 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 7.06 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Myriad Genetics is 6.58 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Myriad Genetics is at 6.94 and 200 DMA is at 6.58, while 50 DMA and 100 DMA are at 7.16 and 7.06 respectively
Myriad Genetics (MYGN) moving average of 20 SMA is at 6.94 and 20 EMA is at 6.84
| Date | Closing Price | 20 SMA | 20 EMA |
| 29 Mon Dec | 6.31 | 6.94 | 6.84 |
| 26 Fri Dec | 6.48 | 7 | 6.9 |
| 24 Wed Dec | 6.55 | 7.06 | 6.94 |
| 23 Tue Dec | 6.56 | 7.13 | 6.98 |
| 22 Mon Dec | 6.76 | 7.19 | 7.02 |
| 19 Fri Dec | 6.55 | 7.22 | 7.05 |
Myriad Genetics (MYGN) moving average of 50 SMA is at 7.16 and 50 EMA is at 7.01
| Date | Closing Price | 50 SMA | 50 EMA |
| 29 Mon Dec | 6.31 | 7.16 | 7.01 |
| 26 Fri Dec | 6.48 | 7.2 | 7.04 |
| 24 Wed Dec | 6.55 | 7.23 | 7.06 |
| 23 Tue Dec | 6.56 | 7.25 | 7.08 |
| 22 Mon Dec | 6.76 | 7.28 | 7.1 |
| 19 Fri Dec | 6.55 | 7.29 | 7.11 |
Myriad Genetics (MYGN) moving average of 100 SMA is at 7.06 and 100 EMA is at 7.05
| Date | Closing Price | 100 SMA | 100 EMA |
| 29 Mon Dec | 6.31 | 7.06 | 7.05 |
| 26 Fri Dec | 6.48 | 7.06 | 7.07 |
| 24 Wed Dec | 6.55 | 7.05 | 7.08 |
| 23 Tue Dec | 6.56 | 7.03 | 7.09 |
| 22 Mon Dec | 6.76 | 7 | 7.1 |
| 19 Fri Dec | 6.55 | 6.97 | 7.11 |
Myriad Genetics (MYGN) moving average of 200 SMA is at 6.58 and 200 EMA is at 8.58
| Date | Closing Price | 200 SMA | 200 EMA |
| 29 Mon Dec | 6.31 | 6.58 | 8.58 |
| 26 Fri Dec | 6.48 | 6.6 | 8.6 |
| 24 Wed Dec | 6.55 | 6.62 | 8.62 |
| 23 Tue Dec | 6.56 | 6.64 | 8.64 |
| 22 Mon Dec | 6.76 | 6.65 | 8.66 |
| 19 Fri Dec | 6.55 | 6.67 | 8.68 |
Myriad Genetics has performed better than Alnylam Pharmaceuticals in short term. Holding Myriad Genetics could be a better choice for now!
Marker Therapeutics has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Marker Therapeutics, about 41.13% more returns!
Mersana Therapeutics has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Mersana Therapeutics, about 15.36% more returns!
Myriad Genetics has performed better than Biolinerx in short term. Holding Myriad Genetics could be a better choice for now!
Intellia Therapeutics has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 19.17% more returns!
Myriad Genetics has performed better than Bioxcel Therapeutics in short term. Holding Myriad Genetics could be a better choice for now!
Celcuity Inc has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Celcuity Inc, about 13.73% more returns!
Cellectis S has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Cellectis S, about 16.83% more returns!
Crinetics Pharmaceuticals has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Crinetics Pharmaceuticals, about 15.64% more returns!
Cytokinetics Incorporated has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 4.11% more returns!
Evolus Inc has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Evolus Inc, about 8.27% more returns!
Esperion Therapeutics has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Esperion Therapeutics, about 15.46% more returns!
Eton Pharmaceuticals has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 19.36% more returns!
National Vision has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in National Vision, about 5.51% more returns!
Surgery Partners has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Surgery Partners, about 2.73% more returns!
Syndax Pharmaceuticals has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 20.82% more returns!
Hutchison China has performed better than Myriad Genetics in short term. You could have earned much better returns by investing in Hutchison China, about 4% more returns!
Myriad Genetics has performed better than Immuron in short term. Holding Myriad Genetics could be a better choice for now!
Myriad Genetics Technical analysis of indicators
Price action analysis of Myriad Genetics (MYGN) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Myriad Genetics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Myriad Genetics in short term and the sell signal is strong.
Myriad Genetics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Myriad Genetics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Myriad Genetics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.66 and Myriad Genetics MYGN stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Myriad Genetics MYGN stock. Volume based technical analysis of Myriad Genetics MYGN stock is negative.
Myriad Genetics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock MYGN Myriad Genetics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MYGN Experts View which covers a lot of information including buying and selling signals
MYGN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Myriad Genetics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Myriad Genetics (MYGN) Technical (Analysis) Reports Myriad Genetics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
